Medicare Coverage Center
- What's New - Opens in a new window
- Draft Guidance - Coverage with Evidence Development in the context of coverage decisions
- Coverage with Evidence Development
- Announcement - CDC Framework for Patient-Centered Health Risk Assessment - Opens in a new window
- FDA/CMS Parallel Review - Opens in a new window
- Medicare Coverage Database - Opens in a new window
- NCAs - Opens in a new window
- NCDs - Opens in a new window
- Index of MEDCAC Meetings - Opens in a new window
- Index of Technology Assessments - Opens in a new window
- Lab NCDs
- Public Comments
Important Links
Coverage Process
- Medicare Coverage Determination Process
- How to Request an NCD
- Local Coverage Determinations
- Potential NCD Topics
- Medicare Evidence Development & Coverage Advisory Committee
Information Exchange
Facilities/Trials/Registries
- Medicare Approved Facilities/Trials/Registries
- Artificial Hearts
- Allogeneic Hematopoietic Stem Cell Transplantation for the treatment of Myelodysplastic Syndromes
- Bariatric Surgery
- Carotid Artery Stenting Facilities
- Carotid Artery Stenting Facility Recertification Process
- ICD Registry
- Intensive Cardiac Rehabilitation (ICR) Programs
- Long Term Oxygen Treatment Trial
- Lung Volume Reduction Surgery (LVRS)
- National Oncologic PET Registry (NOPR)
- Pharmacogenomic Testing to Predict Warfarin Responsiveness
- PET for Cancer
- PET for Dementia Trials
- Transcatheter Aortic Valve Replacement (TAVR)
- VAD Destination Therapy Facilities Aug2007
Coverage with Evidence Development (CED)
- Coverage With Evidence Development
- Allogeneic Hematopoietic Stem Cell Transplantation for the treatment of Myelodysplastic Syndromes
- Anti-Cancer Chemotherapy for Colorectal Cancer (110.17)
- Artificial Hearts
- Autologous Platelet-rich Plasma (PRP)
- Cochlear Implantation
- Continuous Positive Airway Pressure (CPAP) Therapy For Obstructive Sleep Apnea (OSA) (240.4)
- Extracorporeal Photopheresis (ECP) for the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Allograft Transplantation
- Home Use of Oxygen
- Home Use of Oxygen to Treat Cluster Headache
- Magnetic Resonance Angiography (MRA) NCD and the Magnetic Resonance Imaging (MRI) NCD
- Pharmacogenomic Testing to Predict Warfarin Responsiveness
- Positron Emission Tomography (FDG) and Other Neuroimaging Devices for Suspected Dementia
- Positron Emission Tomography (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers
- (NaF-18) Positron Emission Tomography to Identify Bone Metastasis of Cancer
- Positron Emission Tomography (FDG) for Solid Tumors
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcutaneous Electrical Nerve Stimulation (TENS) for chronic low back pain (CLBP)
Coverage Database
- Search - Opens in a new window
- Indexes - Opens in a new window
- Reports - Opens in a new window
- Downloads - Opens in a new window
Coverage Guidance Documents
- Medicare Coverage Guidance Documents
- Draft Guidance - Coverage with Evidence Development in the context of coverage decisions
- Factors CMS Considers in Commissioning External Technology Assessments - Opens in a new window
- Factors CMS Considers in Opening a National Coverage Determination - Opens in a new window
- Factors CMS Considers in Referring Topics to the Medicare Evidence Development and Coverage Advisory Committee - Opens in a new window
Other Coverage Issues
- Medicare Coverage - General Information
- CMS/FDA Memo of Understanding - Opens in a new window
- Compendia 1861 (t)(2) - Anti-cancer
- Medicare Clinical Trial Policies
- Erythropoietin Stimulating Agents Policies
- Mobility Assistive Equipment
